Ajax-Loading

Merck & Company Inc - Deferred Long Term Liabilities

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Deferred-Long-Term-Liabilities" stands at 0.996 Billion United States Dollars as of 06/30/2023, the lowest value at least since 09/30/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -66.51 percent compared to the value the year prior.
The 1 year change in percent is -66.51.
The 3 year change in percent is -52.37.
The 5 year change in percent is -53.87.
The 10 year change in percent is -93.71.

The Serie's long term average value is 6.02 Billion United States Dollars. It's latest available value, on 06/30/2023, is 83.44 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2023, to it's latest available value, on 06/30/2023, is +0.0%.
The Serie's change in percent from it's maximum value, on 06/30/2011, to it's latest available value, on 06/30/2023, is -94.05%.

Deferred Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Deferred Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Deferred Long Term Liabilities486,508,953,600.00
LogoAbbVie Inc - Deferred Long Term Liabilities399,570,305,024.00
LogoRoche Holding AG - Deferred Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Deferred Long Term Liabilities280,205,508,085.11